Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02008435
Other study ID # MOP-123242
Secondary ID
Status Completed
Phase N/A
First received December 6, 2013
Last updated March 20, 2018
Start date April 2013
Est. completion date December 2017

Study information

Verified date March 2018
Source McGill University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Diabetes Prevention Program (DPP) is highly effective in promoting weight loss in overweight and obese individuals (e.g., 7% average loss of body weight), and thereby reducing the risk of developing weight-related health consequences. One-on-one DPP sessions, however, are costly and the group-delivered DPP version, the Group Lifestyle Balance program (GLB), is less effective (4% average loss of body weight). The aim of this two-arm parallel randomized controlled trial is to increase the effectiveness of the GLB by integrating habit formation techniques, namely if-then plans and their mental practice, into the program. The study will provide evidence-based data on the effectiveness of an enhanced GLB intervention in promoting weight loss and in reducing weight-related risk factors for chronic health problems.


Description:

Please see brief summary.


Recruitment information / eligibility

Status Completed
Enrollment 172
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- men and women

- ages of 18 and 75

- overweight or obese (BMI 28-45 kg/m2)

- sedentary (< 200 min/week of moderate or vigorous exercise)

- waist circumference of >= 88cm for women and >= 102cm for men

Exclusion Criteria:

- diabetes (hemoglobin A1c < 7.0%).

- taking the medication metformin (used for treating pre-diabetes or diabetes)

- having been pregnant in the past 6 months or planning on becoming pregnant in the next 2 years

- currently undergoing treatment for cancer

- using medication that affects body weight (e.g., loop diuretics)

- being unable to participate in regular moderate physical activity

- having severe uncontrolled hypertension (> 190/100mm Hg)

- being unable to communicate in English or French

- being diagnosed with bulimia nervosa, currently active major depression, or other severe psychiatric disease (including dementia);

- suffering from a heart attack, stroke, or heart failure within the past 6 months

- experiencing excessive weight loss (more than 10 pounds or 4.54 kilograms) in the past 3 months

- currently participating in another weight loss program

- having had bariatric surgery in the past 2 years or plans on getting it in the near future

- planning on moving away from Montreal within the next year

- having another member of one's household enrolled in the program.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Enriched GLB
Habit formation techniques, namely if-then plans and their mental practice are being added to the standard Group Lifestyle Balance program.
Standard GLB
This arm is the standard Group Lifestyle Balance program

Locations

Country Name City State
Canada McGill University Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
McGill University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Self-Report Index of Habit Strength Self-monitoring and behaviors 3 months
Other Self-Report Index of Habit Strength Self-monitoring and behaviors 12 months
Other Self-Report Index of Habit Strength Self-monitoring and behaviors 24 months
Other Habit formation indices of weight tracking Frequency of weight tracking. 3 months
Other Habit formation indices of weight tracking Frequency of weight tracking. 12 months
Other Habit formation indices of weight tracking Frequency of weight tracking. 24 months
Other Habit formation indices of physical activity tracking Frequency of physical activity tracking. 3 months
Other Habit formation indices of physical activity tracking Frequency of physical activity tracking. 12 months
Other Habit formation indices of physical activity tracking Frequency of physical activity tracking. 24 months
Other Habit formation indices of fat grams and calorie tracking Frequency of food tracking. 3 months
Other Habit formation indices of fat grams and calorie tracking Frequency of food tracking. 12 months
Other Habit formation indices of fat grams and calorie tracking Frequency of food tracking. 24 months
Primary Percent body weight loss The primary outcome will be percent body weight loss from baseline to 3 months after the beginning of the intervention. Weight in kg. 3 months after beginning of the intervention
Secondary Percent body weight loss Percent body weight loss 12 months after the beginning of the intervention. Weight in kg. 12 months
Secondary Percent body weight loss Percent body weight loss 24 months after the beginning of the intervention. Weight in kg. 24 months
Secondary Personal weight loss goal Reaching percent body weight loss goal (7% of body weight) from baseline to 3 months after the beginning of the intervention. Weight in kg. 3 months
Secondary Personal weight loss goal Reaching percent body weight loss goal (7% of body weight) 12 months after the beginning of the intervention. Weight in kg. 12 months
Secondary Personal weight loss goal Reaching percent body weight loss goal (7% of body weight) 24 months after the beginning of the intervention. Weight in kg. 24 months
Secondary Personal exercise goal Reaching exercise goal (150 min/week) from baseline to 3 months after the beginning of the intervention. Sum of minutes over 7 days. 3 months
Secondary Personal exercise goal Reaching exercise goal (150 min/week) 12 months after the beginning of the intervention. Sum of minutes over 7 days. 12 months
Secondary Personal exercise goal Reaching exercise goal (150 min/week) 24 months after the beginning of the intervention. Sum of minutes over 7 days. 24 months
Secondary Waist circumference Risk factor for chronic health problems. 3 months
Secondary Waist circumference Risk factor for chronic health problems. 12 months
Secondary Waist circumference Risk factor for chronic health problems. 24 months
Secondary Hemoglobin A1c levels Risk factor for chronic health problems. 3 months
Secondary Hemoglobin A1c levels Risk factor for chronic health problems. 12 months
Secondary Hemoglobin A1c levels Risk factor for chronic health problems. 24 months
Secondary Blood pressure Risk factor for chronic health problems. 3 months
Secondary Blood pressure Risk factor for chronic health problems. 12 months
Secondary Blood pressure Risk factor for chronic health problems. 24 months
Secondary Total cholesterol/HDL ratio Risk factor for chronic health problems. 3 months
Secondary Total cholesterol/HDL ratio Risk factor for chronic health problems. 12 months
Secondary Total cholesterol/HDL ratio Risk factor for chronic health problems. 24 months
Secondary Physical activity duration Total minutes per week. 3 months
Secondary Physical activity duration Total minutes per week. 12 months
Secondary Physical activity duration Total minutes per week. 24 months
Secondary Number of steps taken per week Steps taken per week, recorded using a pedometer. 3 months
Secondary Number of steps taken per week Steps taken per week, recorded using a pedometer. 12 months
Secondary Number of steps taken per week Steps taken per week, recorded using a pedometer. 24 months
Secondary Exercise stress test (EST) 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2